Table 2.
Expanded field services outcomes, populations in which outcomes should be measured and program evaluation metrics
| Field Services Outcomes | Populations in which outcome may be relevant | Proposed Program Evaluation Metrics |
|---|---|---|
| Partner notification, testing and treatment | Newly diagnosed HIV infection Bacterial STI HIV-infected index patients and partners who are out of care |
|
| HIV testing and retesting | Index cases with bacterial STIs Partners of index cases receiving STI partner services |
|
| Increase condom use | Index cases and partners receiving HIV or STI partner services |
|
| Referral for PrEP | Index cases at high risk for HIV receiving STI partner services+ Sex partners of persons with HIV or early syphilis |
|
| Linkage to HIV care | Index cases receiving HIV partner services |
|
| Relinkage to HIV care | Index cases receiving STI partner services who are found to be out of care, partners of persons receiving partner services found to be out of care |
|
| Increase use of effective contraception | Women receiving partner services and female partners of persons receiving partner services who do not desire pregnancy and are not using long-acting contraception |
|
| Referral for health insurance | Uninsured persons (index cases ore partners) identified through partner services |
|
Outcomes should be evaluated using verified (confirmed by DIS) and unverified dispositions (index patient report alone). Also, timing of partner HIV notification and testing relative to index patient interview should ideally be measured to define notification and testing occurring prior to PS intervention. Outcomes best evaluated as indices (events per index case receiving PS)
PrEP referral should ideally be guided by local epidemiology on HIV risks. Throughout the U.S., persons with an HIV-infected sex partner who is not on antiretrovirals, MSM with early syphilis or rectal gonorrhea and MSM who use methamphetamine are at high risk for HIV and should be offered PrEP.
Condom use should ideally be monitored at the population-level using sentinel (e.g. STD clinic data) and population-based (e.g. National HIV Behavioral Surveillance, Behavioral Risk Factor Surveillance) surveillance sources of data.
DIS should ask all HIV-infected persons contacted through partner services if they have an HIV medical provider, when they last saw that provider, when they are scheduled to see their provider next, and if they are taking ART. Persons without a medical provider or with no follow-up planned should be relinked to care. Public health programs should seek to promote universal ART use through partner services.